US Stem Cell Inc (USRM)

[Dragon Lady]

"The patient investor always has the greatest chance to receive a great return. Here with BHRT, patient investors have recognized value and are willing to stay the course."????

It would appear to me that the "patient BHRT investor" has been nearly wiped out? Their (BHRT's) initial large investors were nearly totally wiped out, if not wiped out, when several key loans went into default. The stock is down, at a loss of about 98% to almost 99% from their IPO date of Feb 2008 at $5 a share, to a recent all time low of .0063 in Dec 2013, and then most recent trading of about 1.5 cents to maybe 2 or 3 cents tops?

http://venturebeat.com/2008/02/19/three-yards-and-a-cloud-of-dust-bioheart-makes-it-across-the-ipo-goal-line-but-with-little-to-show-for-its-struggles/

In just the first year after the IPO, the stock dropped from $5 a share in 2008, to $1 or so a share in 2009, and was de-listed from the NASDAQ, almost exactly only 1 yr after the IPO date. "Value" for the long term?

How exactly did, or is that producing "value" for "patient" (long term I guess?) "investors"? A 98% loss for those who've gone long? Just since the present CEO took over in 2010, the stock has lost about 95% or more in "value" from .50 cents or more in 2010, to now about 2 cents? It's also faced massive, massive dilution along the way, from less than 40 million shares of common outstanding in mid 2011, to now more than 500 MILLION and climbing rapidly?

From 10-K:
" The number of shares outstanding of the registrant’s Common Stock, $0.001 Par Value, as of May 10, 2011 was 42,600,569. "

From recent 10-Q:
"As of August 1, 2014, there were 517,272,472 outstanding shares of the Registrant’s common stock, par value $0.001 per share."

What exactly is this long term "value", would be fascinating IMHO to see this explained in more depth?